Rier S E, Parsons A K, Becker J L
Department of Medical Microbiology and Immunology, University of South Florida College of Medicine, Tampa 33606.
Fertil Steril. 1994 Feb;61(2):294-9. doi: 10.1016/s0015-0282(16)56520-0.
To investigate the ability of peritoneal leukocytes to produce interleukin-6 (IL-6) in vitro and to determine whether IL-6 is present in the peritoneal fluid (PF) in vivo.
Peritoneal leukocytes were assessed for spontaneous versus stimulated IL-6 production. Interleukin-6 in the PF was also quantitated.
Leukocytes were recovered from PF obtained at the time of diagnostic laparoscopy for pain and infertility or from women undergoing bilateral tubal ligation.
The study population included a total of 24 women. Experimental groups consisted of women undergoing tubal ligations (n = 6), patients with postinflammatory pelvic adhesions unrelated to endometriosis (n = 6), and women with minimal to mild endometriosis (n = 6), or moderate to severe disease (n = 6).
Peritoneal leukocytes from normal control women and patients with severe endometriosis spontaneously produced low levels of IL-6. In contrast, cells from women with mild disease or adhesions spontaneously released twofold to fourfold higher levels of this cytokine. Peritoneal leukocytes from patients with both mild and severe endometriosis were refractory to additional cytokine release directly in response to stimulation with endotoxin. Bioactive IL-6 was present in the PF of all patient groups, whereas immunoreactive IL-6 was not detected in this fluid.
These data demonstrate that IL-6 was present in the PF of all patient groups. However, the ability of peritoneal leukocytes to produce IL-6 in vitro differed according to stage of disease. We hypothesize that altered leukocyte IL-6 production in vivo may contribute to the pathophysiology of endometriosis.
研究腹膜白细胞在体外产生白细胞介素-6(IL-6)的能力,并确定体内腹膜液(PF)中是否存在IL-6。
评估腹膜白细胞自发与受刺激产生IL-6的情况。同时对PF中的白细胞介素-6进行定量分析。
白细胞从因疼痛和不孕接受诊断性腹腔镜检查时获取的PF中分离,或从接受双侧输卵管结扎的女性体内获取。
研究人群共包括24名女性。实验组包括接受输卵管结扎的女性(n = 6)、患有与子宫内膜异位症无关的炎症后盆腔粘连的患者(n = 6)、患有轻度至中度子宫内膜异位症的女性(n = 6)或重度疾病患者(n = 6)。
正常对照女性和重度子宫内膜异位症患者的腹膜白细胞自发产生低水平的IL-6。相比之下,轻度疾病或粘连女性的细胞自发释放的这种细胞因子水平高出两到四倍。轻度和重度子宫内膜异位症患者的腹膜白细胞对内毒素刺激直接产生的额外细胞因子释放具有抗性。所有患者组的PF中均存在生物活性IL-6,而该液体中未检测到免疫反应性IL-6。
这些数据表明所有患者组的PF中均存在IL-6。然而,腹膜白细胞在体外产生IL-6的能力因疾病阶段而异。我们推测体内白细胞IL-6产生的改变可能有助于子宫内膜异位症的病理生理过程。